Skip to content

Plasma proteomics study of patients with urosepsis after percutaneous nephrolithotomy

Plasma proteomics study of patients with urosepsis after percutaneous nephrolithotomy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500109414
Enrollment
Unknown
Registered
2025-09-18
Start date
2025-09-25
Completion date
Unknown
Last updated
2025-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

Urosepsis group:None
Non-urosepsis group:None

Sponsors

The First Affiliated Hospital, University of South China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >=18 years old; 2. American Society of Anesthesiologists (ASA) physical status I–III; 3. Scheduled for one-stage percutaneous nephrolithotomy (PCNL); 4.Voluntary to participate and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Scheduled for two-stage percutaneous nephrolithotomy (PCNL); 2. Missing key clinical data; 3. Uremia or history of renal surgery; 4. Tumors, hematological diseases or immune system disorders; 5. Urogenital tract malformations; 6. Pregnant or breastfeeding patients; 7. Participating in other clinical trials within the past 3 months.

Design outcomes

Primary

MeasureTime frame
Proteomics;

Countries

China

Contacts

Public ContactYiheng Wang

The First Affiliated Hospital, University of South China

wyheng11@163.com+86 183 7348 2898

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026